Screener
Pacira BioSciences, Inc. PCRX Accounts Payable
Accounts Payable at other companies
Other financials
Where this comes from
Reported directly by Pacira BioSciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccountsPayableCurrent.
The source filing: Pacira BioSciences, Inc.’s 10-Q, filed April 30, 2026.
- Filed
- Apr 30, 2026, 4:07 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028871
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Total assets | $1,208,534 | $1,264,917 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| Current liabilities: | ||
| Accounts payable | $14,012 | $15,150 |
| Accrued expenses | 84,957 | 95,601 |
| Lease liabilities | 9,818 | 9,839 |
| Total current liabilities | 108,787 | 120,590 |
| Long-term debt, net | 367,656 | 372,189 |
Item 1. FINANCIAL STATEMENTS (Unaudited)
FAQ
- What is Pacira BioSciences, Inc.'s accounts payable?
- Pacira BioSciences, Inc. (PCRX) reported accounts payable of $14.01M in Q1 2026.
- How has Pacira BioSciences, Inc.'s accounts payable changed year-over-year?
- Pacira BioSciences, Inc.'s accounts payable decreased by 39.5% year-over-year, from $23.17M to $14.01M.
- What is the long-term trend for Pacira BioSciences, Inc.'s accounts payable?
- Over 5 years (2020 to 2025), Pacira BioSciences, Inc.'s accounts payable has grown at a 7.8% compound annual growth rate (CAGR), from $10.43M to $15.15M.
- What does accounts payable mean?
- Amounts owed to suppliers and vendors for goods and services received but not yet paid. A primary source of short-term trade financing.
Ask your AI about Pacira BioSciences, Inc.'s accounts payable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude